API Product   :    Trimetazidine Di HCI
CEP   :    -
WCC   :    ?
Therapeutic Use    :    Cardiac therapy; Cerebral and peripheral vasotherapeutics
Originator   :    Servier
CAS No.    :    5011-34-7
Trade Name.   :    Vastarel
Molecular Weight   :    266.336 g/mol
Molecular Formula   :    C14H22N2O3
Trimetazidine is a drug for angina pectoris sold under many brand names. ... Trimetazidine is an anti-ischemic (anti-anginal) metabolic agent, which improves myocardial glucose utilization through inhibition of fatty acid metabolism, also known as fatty acid oxidation inhibitor.
Trimetazidine is a drug for angina pectoris sold under many brand names.[1] Trimetazidine is described as the first cytoprotective anti-ischemic agent developed and marketed by Laboratoires Servier (France). Trimetazidine is an anti-ischemic (anti-anginal) metabolic agent, which improves myocardial glucose utilization through inhibition of fatty acid metabolism, also known as fatty acid oxidation inhibitor.